Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q4 2016 call → NOWe need to determine if management conveys that the company's current business is visibly outgrowing its own size. The transcript discusses various projects, acquisitions, and growth. Key points: They have $100 million cash for acquisitions, but no specific deals mentioned. They have projects like Torrey Plaza, Oregon Square, Waikele. They mention FFO growth 5%, same store NOI 5%. They discuss Hassalo occupancy adjustments. They mention a private placement and ATM issuance. They talk about being conservative. There is no explicit statement that the company is small and that current activity is disproportionately large relative to its size. They mention they are looking for acquisitions but nothing concrete. They mention they have a dedicated acquisition associate. They talk about repositioning projects. But no clear statement of "we are small and this is huge relative to us." The company is a REIT with a portfolio. They discuss growth but not in a way that conveys a disproportion. They mention that they have $100 million cash to deploy, but that's not necessarily large relative to their size. They have a market cap? Not given. They talk about potential acquisitions but not committed. The question asks if management conveys that the business they are doing RIGHT NOW is visibly outgrowing the company's own current size. They mention that they are actively looking for deals, but no specific large commitments. They mention that they have interest in Waikele, but that's a single property. They mention that they are one of three finalists for a build-to-suit, but that's prospective. They mention that they have signed LOI with a national grocer, but that's a lease, not necessarily disproportionate. The overall tone is steady growth, not a small company being overwhelmed by large opportunities. They are a public company with a portfolio. They don't describe themselves as small. They talk about NAV growth. I think the answer is NO. They don't convey that the current business is disproportionately large relative to their size. They are just doing normal business. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.